Detalhe da pesquisa
1.
Quantitative liver function tests improve the prediction of clinical outcomes in chronic hepatitis C: results from the Hepatitis C Antiviral Long-term Treatment Against Cirrhosis Trial.
Hepatology
; 55(4): 1019-29, 2012 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-22030902
2.
Rate of progression of hepatic fibrosis in patients with chronic hepatitis C: results from the HALT-C Trial.
Gastroenterology
; 141(3): 900-908.e1-2, 2011 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-21699796
3.
Effect of HCV RNA suppression during peginterferon alfa-2a maintenance therapy on clinical outcomes in the HALT-C trial.
Gastroenterology
; 137(6): 1986-94, 2009 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-19747918
4.
Evolution of hepatic steatosis in patients with advanced hepatitis C: results from the hepatitis C antiviral long-term treatment against cirrhosis (HALT-C) trial.
Hepatology
; 49(6): 1828-37, 2009 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-19291787
5.
Coffee intake is associated with lower rates of liver disease progression in chronic hepatitis C.
Hepatology
; 50(5): 1360-9, 2009 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-19676128
6.
Seventy-two weeks of peginterferon and ribavirin for patients with partial early virologic response?
Hepatology
; 46(6): 1671-4, 2007 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-18046713
7.
Impact of disease severity on outcome of antiviral therapy for chronic hepatitis C: Lessons from the HALT-C trial.
Hepatology
; 44(6): 1675-84, 2006 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-17133499